Stryker Corporation Stock Price and Value Analysis

Stryker Corporation (NYSE:SYK) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: SYK (NYSE)
  • Current price: $310.00
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield: 1.12%

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Stryker Corporation to reach your target.

Target type

SYK Free Cash Flow Trend

Free Cash Flow trendline for SYK
Free Cash Flow trendline for Stryker Corporation
CSV

Based on historical returns, we believe that Stryker Corporation can grow its free cash at a rate of about 8%. That's positive!

AdvantagesDisadvantages
  • This company has fluctuating growth.
  • This company is making money at a decent rate.
  • This company is very stable.
  • This stock looks overpriced.
  • This company has a low dividend yield.

Inside the SYK Numbers

SYK Price
(Stryker Corporation stock price per share)
$310.00
[?] SYK Fair Price
(based on intrinsic value)
$84.86
[?] SYK Safety Price (based on a variable margin of safety) $67.89
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 105% higher than other Unknown stocks
[?] PE Ratio versus Industry 281% higher than other Unknown stocks
[?] Cash Yield 0.86%
[?] Free Cash Flow Jitter 27%
[?] Dividend Yield 1.12% (tax impact)
Shares Shorted 6,660,553

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 6,660,553 shares shorted. With 345,823,515 shares available for purchase and an average trading volume over the past 10 trading days of 3,039,910, it would take at least 2.2 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2007 310764 841
2008 310764 1,004
2009 310764 1,303
2010 310764 1,383
2011 310764 1,258
2012 310764 1,476
2013 310764 1,697
2014 310764 1,573
2015 310764 754
2016 310764 1,635
2017 310764 1,202
2018 310764 2,177
2019 310764 1,675
2020 310764 2,718
2021 310764 2,697
2022 310764 2,060
2023 310764 3,146
2024 310764 3,656
2025 310764 4,403

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 19 fiscal years from 2007 to 2025 with positive net income, operating cash flow totaled $43,388 million against net income of $33,806 million, or 1.28 times.

In 2025, operating cash flow was 1.55 times net income, compared with 1.12 times for the earliest three years (2007 to 2009).

In 2025, capital expenditures were $761 million, 15.1% of operating cash flow of $5,044 million, which leaves an estimated $4,283 million after capex. Across the 19 years with reported capex, it averaged 18.0% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2007 1,017 1,028 188 1.01
2008 1,148 1,176 155 1.02
2009 1,107 1,461 131 1.32
2010 1,273 1,547 182 1.22
2011 1,345 1,434 226 1.07
2012 1,298 1,657 210 1.28
2013 1,006 1,886 195 1.87
2014 515 1,782 233 3.46
2015 1,439 981 270 0.68
2016 1,647 1,915 490 1.16
2017 1,020 1,559 598 1.53
2018 3,553 2,610 572 0.73
2019 2,083 2,191 649 1.05
2020 1,599 3,277 487 2.05
2021 1,994 3,263 525 1.64
2022 2,358 2,624 588 1.11
2023 3,165 3,711 575 1.17
2024 2,993 4,242 755 1.42
2025 3,246 5,044 761 1.55

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $25,370 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $9,191 million, 36.2% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 3 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $837 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends paid were $1,284 million, 29.2% of estimated free cash flow of $4,403 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 1,635 568 13 581 35.5%
2017 1,202 636 230 866 72.1%
2018 2,177 703 300 1,003 46.1%
2019 1,675 778 307 1,085 64.8%
2020 2,718 863 n/a 863 31.8%
2021 2,697 950 n/a 950 35.2%
2022 2,060 1,051 n/a 1,051 51.0%
2023 3,146 1,139 n/a 1,139 36.2%
2024 3,656 1,219 n/a 1,219 33.3%
2025 4,403 1,284 n/a 1,284 29.2%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $6,001 million in 2007 and $25,116 million in 2025, a compound annual growth rate of 8.3% over 18 years.

Revenue rose 11.2% from 2024 to 2025.

Our estimated free cash flow was $4,403 million in 2025, 17.5% of revenue. In 2007 the estimated margin was 14.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2007 6,001 841 14.0%
2008 6,718 1,004 15.0%
2009 6,723 1,303 19.4%
2010 7,320 1,383 18.9%
2011 8,307 1,258 15.1%
2012 8,657 1,476 17.1%
2013 9,021 1,697 18.8%
2014 9,675 1,573 16.3%
2015 9,946 754 7.6%
2016 11,325 1,635 14.4%
2017 12,444 1,202 9.7%
2018 13,601 2,177 16.0%
2019 14,884 1,675 11.3%
2020 14,351 2,718 18.9%
2021 17,108 2,697 15.8%
2022 18,449 2,060 11.2%
2023 20,498 3,146 15.3%
2024 22,595 3,656 16.2%
2025 25,116 4,403 17.5%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $4,011 million against total liabilities of $25,424 million, or 15.8% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 53.1% of total assets in 2025, compared with 28.9% in 2008, an increase of 24.3 percentage points.

Stockholders equity was $22,420 million in 2025, compared with $5,408 million in 2008, a rise of 314.6%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 12.2% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2008 7,603 701 2,195 5,408
2009 9,071 659 2,475 6,596
2010 10,658 1,758 3,721 7,174
2011 12,146 905 4,463 7,683
2012 13,206 1,395 4,609 8,597
2013 15,399 1,339 6,696 9,047
2014 17,258 1,795 8,684 8,595
2015 16,223 3,379 7,712 8,511
2016 20,435 3,316 10,885 9,550
2017 22,197 2,542 12,217 9,980
2018 27,229 3,616 15,499 11,730
2019 30,167 4,337 17,360 12,807
2020 34,330 2,943 21,246 13,084
2021 34,631 2,944 19,754 14,877
2022 36,884 1,844 20,268 16,616
2023 39,912 2,971 21,319 18,593
2024 42,971 3,652 22,337 20,634
2025 47,844 4,011 25,424 22,420

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $310.00, our model's value equals that price if free cash flow grows an average of 30.5 percent a year over the 10 projection years. Our model assumes 7.8 percent a year for this stock, so the price implies growth of 30.5 percent, which is above the 7.8 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 30.5 percent a year, free cash flow would grow about 14.3 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $1,026 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $248.00 26.9%
Current price $310.00 30.5%
20 percent above the current price $372.00 33.4%
Our model (stored fair price) $84.86 7.8%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Free cash flow was positive in all 19 fiscal years we have for Stryker Corporation under its current SEC filer.

Average free cash flow over the last three years of data was $3,735 million, and across the first three years it was $1,049 million; over the period it rose sharply.

Free cash flow is uneven from year to year, with a variability measure of 27%.

At $310.00, the price is above our fair value estimate of $84.86 for Stryker Corporation.

Stryker Corporation yields 1.12% in dividends.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 310764.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: SYK annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in SYK

Does Stryker Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: SYK

This example shows how we apply the Trendshare checklist to SYK: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 310.00
    • Market cap: $118B
    • EPS: 9.39
  2. Step 2 — Valuation checks

    • P/E: 33.014
    • FCF yield: 0.9%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.